PriceTargets.com logo

Profound Medical - PROF Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $11.00
  • Forecasted Upside: 62.96%
  • Number of Analysts: 2
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$6.75 As of 12/4/2025 05:00 PM ET
▼ -0.15 (-2.17%)

This chart shows the closing price for PROF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Profound Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PROF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PROF

Analyst Price Target is $11.00
▲ +62.96% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Profound Medical in the last 3 months. The average price target is $11.00, with a high forecast of $11.00 and a low forecast of $11.00. The average price target represents a 62.96% upside from the last price of $6.75.

This chart shows the closing price for PROF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 2 polled investment analysts is to hold stock in Profound Medical. This rating has held steady since September 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 1 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
5/9/2025Raymond James FinancialDowngradeStrong-Buy ➝ Moderate Buy
4/23/2025Lake Street CapitalLower TargetBuy ➝ Buy$17.00 ➝ $11.00
11/9/2024Raymond James FinancialUpgradeStrong-Buy
7/23/2024Lake Street CapitalInitiated CoverageBuy$16.50
7/16/2024Stifel NicolausUpgradeHold ➝ Buy$9.00 ➝ $12.00
1/4/2024Alliance Global PartnersLower TargetBuy ➝ Buy$14.25 ➝ $12.75
11/28/2023Stifel NicolausInitiated CoverageHold$11.00
9/18/2023Raymond James FinancialUpgradeOutperform ➝ Strong-Buy$20.00
8/4/2023Raymond James FinancialDowngradeStrong-Buy ➝ Outperform
6/5/2023Raymond James FinancialBoost TargetStrong-Buy$17.00 ➝ $20.00
3/21/2023Jefferies Financial GroupDowngradeBuy ➝ Hold$5.50 ➝ $10.00
3/8/2023Raymond James FinancialBoost TargetStrong-Buy$15.00 ➝ $17.00
1/6/2023Lake Street CapitalBoost Target$7.00 ➝ $14.00
11/4/2022Alliance Global PartnersLower TargetBuy ➝ Buy$12.50 ➝ $6.50
11/4/2022Raymond James FinancialUpgradeOutperform ➝ Strong-Buy$15.00
9/28/2022Raymond James FinancialSet TargetOutperform$15.00
8/8/2022Raymond James FinancialLower TargetOutperform$17.50 ➝ $15.00
7/18/2022Raymond James FinancialLower TargetOutperform$22.00 ➝ $17.50
5/10/2022Alliance Global PartnersLower TargetBuy$16.25 ➝ $12.00
5/10/2022Raymond James FinancialSet TargetOutperform$22.00
4/25/2022Raymond James FinancialSet TargetOutperform$22.00
3/21/2022Raymond James FinancialLower TargetOutperform$23.00 ➝ $22.00
3/7/2022CowenLower TargetOutperform$28.00 ➝ $14.00
3/2/2022Raymond James FinancialSet TargetOutperform$23.00
2/22/2022Raymond James FinancialDowngradeStrong-Buy ➝ Outperform$28.00 ➝ $23.00
1/20/2022Raymond James FinancialSet TargetStrong-Buy$28.00
1/19/2022Raymond James FinancialBoost TargetStrong-Buy$35.00
12/2/2021Raymond James FinancialSet TargetStrong-Buy$28.00
11/8/2021Raymond James FinancialLower TargetStrong-Buy$30.00 ➝ $28.00
10/27/2021Raymond James FinancialLower TargetStrong-Buy$36.00 ➝ $30.00
9/30/2021Raymond James FinancialSet TargetStrong-Buy$36.00
9/29/2021Raymond James FinancialBoost TargetStrong-Buy$46.00
8/26/2021Raymond James FinancialSet TargetStrong-Buy$36.00
8/5/2021Raymond James FinancialSet TargetStrong-Buy$36.00
7/1/2021Raymond James FinancialSet TargetStrong-Buy$36.00
6/30/2021Raymond James FinancialBoost TargetStrong-Buy$44.50
6/21/2021Raymond James FinancialReiterated RatingStrong-Buy$36.00
5/13/2021Alliance Global PartnersLower TargetBuy$28.25 ➝ $21.00
5/10/2021Raymond James FinancialSet TargetStrong-Buy$36.00
5/4/2021Raymond James FinancialBoost TargetStrong-Buy$34.00 ➝ $36.00
3/29/2021Raymond James FinancialReiterated RatingStrong-Buy$34.00
3/10/2021Raymond James FinancialReiterated RatingStrong-Buy$34.00
3/4/2021Leede Jones GabReiterated RatingBuy
1/25/2021Lake Street CapitalBoost Target$27.00 ➝ $32.00
1/7/2021Alliance Global PartnersBoost TargetBuy$20.25 ➝ $28.25
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.57 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 6 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 5 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
9/5/2025
  • 0 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 8 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 8 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Profound Medical logo
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
Read More

Today's Range

Now: $6.75
Low: $6.65
High: $7.00

50 Day Range

MA: $5.99
Low: $4.89
High: $6.90

52 Week Range

Now: $6.75
Low: $3.76
High: $8.36

Volume

61,412 shs

Average Volume

97,093 shs

Market Capitalization

$203.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Profound Medical?

The following Wall Street sell-side analysts have issued reports on Profound Medical in the last twelve months: Lake Street Capital, Raymond James Financial, Inc., Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for PROF.

What is the current price target for Profound Medical?

0 Wall Street analysts have set twelve-month price targets for Profound Medical in the last year. Their average twelve-month price target is $11.00, suggesting a possible upside of 60.2%. Lake Street Capital has the highest price target set, predicting PROF will reach $11.00 in the next twelve months. Lake Street Capital has the lowest price target set, forecasting a price of $11.00 for Profound Medical in the next year.
View the latest price targets for PROF.

What is the current consensus analyst rating for Profound Medical?

Profound Medical currently has 1 sell rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PROF, but not buy more shares or sell existing shares.
View the latest ratings for PROF.

What other companies compete with Profound Medical?

Other companies that are similar to Profound Medical include Embecta, CeriBell, Bioventus, Tactile Systems Technology and Avanos Medical. Learn More about companies similar to Profound Medical.

How do I contact Profound Medical's investor relations team?

Profound Medical's physical mailing address is 2400 SKYMARK AVENUE UNIT 6, MISSISSAUGA A6, L4W 5K5. The company's listed phone number is (647) 476-1350 and its investor relations email address is [email protected]. The official website for Profound Medical is www.profoundmedical.com. Learn More about contacing Profound Medical investor relations.